Advice

Following an abbreviated submission

Dinoprostone 10mg vaginal delivery system (Propess) is accepted for use in NHS Scotland for initiation of cervical ripening in patients at term (from 38th week of gestation)

This formulation replaces a product which released 5mg over 12 hours from a different 10 mg vaginal delivery system. The new pessary formulation can remain in place for up to 24 hours where necessary and the cost per pessary is unchanged.

Download detailed advice29KB (PDF)

Download

Medicine details

Medicine name:
dinoprostone 10mg vaginal delivery system (Propess)
SMC ID:
283/06
Indication:
Cervical ripening in patients at term (from 38th week of gestation)
Pharmaceutical company
Ferring Pharmaceuticals Ltd
BNF chapter
Obstetrics, gynaecology, and urinary-tract disorders
Submission type
Abbreviated
Status
Accepted
Date advice published
10 July 2006